Accountability to oneself and fostering community confidence:
Uphold academic integrity and inspire trust within the academic community
RDD搜索
搜索
搜索结果 ：
RDD 编号
论文/项目标题
LM-101, an anti-SIRPα antibody, in patients with relapsed/refractory lymphoma and advanced head and neck cancer: an open-label, multicenter, phase 1 trial
作者列表
Jun Cai
caijun@sysucc.org.cn
Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China.
通讯作者
Baitian Zhao
zhaobt@sysucc.org.cn
Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China.
通讯作者
Shenrui Bai
baisr@sysucc.org.cn
Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China.
通讯作者
Xiaojie Fang
fangxj@sysucc.org.cn
Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China.
通讯作者
Man Nie
nieman@sysucc.org.cn
Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China.
通讯作者
Bing Bai
baibing@sysucc.org.cn
Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China.
通讯作者
Yuchen Zhang
zhangyc1@sysucc.org.cn
Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China.
通讯作者
Yi Xia
xiayi@sysucc.org.cn
Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China.
通讯作者
Qingqing Cai
caiqq@sysucc.org.cn
Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China.
搜索
